IMMUNOMODULATORY AGENTS AND PROTEASOME INHIBITORS IN THE TREATMENT OF MULTIPLE MYELOMA

被引：11

作者：

Noonan, Kimberly ^{[1
]}

Colson, Kathleen ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA

来源：

SEMINARS IN ONCOLOGY NURSING | 2017年 / 33卷 / 03期

关键词：

multiple myeloma; immunomodulatory drugs; proteasome inhibitors; treatment; side effects; LENALIDOMIDE PLUS DEXAMETHASONE; STEM-CELL TRANSPLANTATION; LOW-DOSE DEXAMETHASONE; NEWLY-DIAGNOSED MYELOMA; LONG-TERM SURVIVAL; ELDERLY-PATIENTS; OPEN-LABEL; CONSENSUS STATEMENT; ANTITUMOR-ACTIVITY; ORAL MELPHALAN;

D O I：

10.1016/j.soncn.2017.05.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OBJECTIVE: To review the current evidence on the use of immunomodulatory agents (IMiDs) and proteasome inhibitors (PIs) in the treatment of multiple myeloma (MM). DATA SOURCES: Journal articles, research reports, state of the science papers, and clinical guidelines. CONCLUSION: There has been a tremendous increase of new agents to treat multiple myeloma in the last 15 years. The IMiDs and PIs remain essential components of many anti-myeloma regimens. IMPLICATIONS FOR NURSING PRACTICE: With these advances in the therapeutic landscape, knowledge of these drugs, side effects and nursing implications are essential to improve outcomes. Patient education is also of vital importance in achieving optimal responses to treatment.

引用

页码：279 / 291

页数：13

共 88 条

[41] Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma [J].

Ludwig, Heinz ;

Hajek, Roman ;

Tothova, Elena ;

Drach, Johannes ;

Adam, Zdenek ;

Labar, Boris ;

Egyed, Miklos ;

Spicka, Ivan ;

Gisslinger, Heinz ;

Greil, Richard ;

Kuhn, Ingrid ;

Zojer, Niklas ;

Hinke, Axel .

BLOOD, 2009, 113 (15) :3435-3442

[42] Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 [J].

Lyman, Gary H. ;

Bohlke, Kari ;

Khorana, Alok A. ;

Kuderer, Nicole M. ;

Lee, Agnes Y. ;

Arcelus, Juan Ignacio ;

Balaban, Edward P. ;

Clarke, Jeffrey M. ;

Flowers, Christopher R. ;

Francis, Charles W. ;

Gates, Leigh E. ;

Kakkar, Ajay K. ;

Key, Nigel S. ;

Levine, Mark N. ;

Liebman, Howard A. ;

Tempero, Margaret A. ;

Wong, Sandra L. ;

Somerfield, Mark R. ;

Falanga, Anna .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :654-U174

[43] Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma [J].

McCarthy, Philip L. ;

Owzar, Kouros ;

Hofmeister, Craig C. ;

Hurd, David D. ;

Hassoun, Hani ;

Richardson, Paul G. ;

Giralt, Sergio ;

Stadtmauer, Edward A. ;

Weisdorf, Daniel J. ;

Vij, Ravi ;

Moreb, Jan S. ;

Callander, Natalie Scott ;

Van Besien, Koen ;

Gentile, Teresa ;

Isola, Luis ;

Maziarz, Richard T. ;

Gabriel, Don A. ;

Bashey, Asad ;

Landau, Heather ;

Martin, Thomas ;

Qazilbash, Muzaffar H. ;

Levitan, Denise ;

McClune, Brian ;

Schlossman, Robert ;

Hars, Vera ;

Postiglione, John ;

Jiang, Chen ;

Bennett, Elizabeth ;

Barry, Susan ;

Bressler, Linda ;

Kelly, Michael ;

Seiler, Michele ;

Rosenbaum, Cara ;

Hari, Parameswaran ;

Pasquini, Marcelo C. ;

Horowitz, Mary M. ;

Shea, Thomas C. ;

Devine, Steven M. ;

Anderson, Kenneth C. ;

Linker, Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) :1770-1781

[44] Autologous Hematopoietic Stem Cell Transplantation for Patients With Multiple Myeloma: An Overview for Nurses in Community Practice [J].

Miceli, Teresa ;

Lilleby, Kathryn ;

Noonan, Kimberly ;

Kurtin, Sandra ;

Faiman, Beth ;

Mangan, Patricia A. .

CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (06) :13-24

[45]

Millenium Pharmaceuticals, 2017, NINL PACK INS

[46]

Millenium Pharmaceuticals, 2017, VELC PACK INS

[47] Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma [J].

Moreau, P. ;

Masszi, T. ;

Grzasko, N. ;

Bahlis, N. J. ;

Hansson, M. ;

Pour, L. ;

Sandhu, I. ;

Ganly, P. ;

Baker, B. W. ;

Jackson, S. R. ;

Stoppa, A. -M. ;

Simpson, D. R. ;

Gimsing, P. ;

Palumbo, A. ;

Garderet, L. ;

Cavo, M. ;

Kumar, S. ;

Touzeau, C. ;

Buadi, F. K. ;

Laubach, J. P. ;

Berg, D. T. ;

Lin, J. ;

Di Bacco, A. ;

Hui, A. -M. ;

van de Velde, H. ;

Richardson, P. G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17) :1621-1634

[48] Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study [J].

Moreau, Philippe ;

Pylypenko, Halyna ;

Grosicki, Sebastian ;

Karamanesht, Ievgenii ;

Leleu, Xavier ;

Rekhtman, Grigoriy ;

Masliak, Zvenyslava ;

Robak, Pawel ;

Esseltine, Dixie-Lee ;

Feng, Huaibao ;

Deraedt, William ;

van de Velde, Helgi ;

Arnulf, Bertrand .

HAEMATOLOGICA, 2015, 100 (05) :e207-e210

[49]

Noonan K., 2016, ADV ONCOLOGY NURSING, P397

[50]

Offidani M, 2006, HAEMATOLOGICA, V91, P133

← 1 2 3 4 5 6 7 8 9 →